

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 8.73337037 |
| 2 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 8.21968774 |
| 3 | ATP synthesis coupled proton transport (GO:0015986) | 8.21968774 |
| 4 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 8.07298963 |
| 5 | respiratory electron transport chain (GO:0022904) | 7.14915322 |
| 6 | electron transport chain (GO:0022900) | 6.99328082 |
| 7 | chaperone-mediated protein transport (GO:0072321) | 5.58302051 |
| 8 | * protein complex biogenesis (GO:0070271) | 5.27151538 |
| 9 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 5.22813788 |
| 10 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 5.22813788 |
| 11 | NADH dehydrogenase complex assembly (GO:0010257) | 5.22813788 |
| 12 | protein neddylation (GO:0045116) | 5.13860623 |
| 13 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.78916344 |
| 14 | * mitochondrial respiratory chain complex assembly (GO:0033108) | 4.75738941 |
| 15 | hydrogen ion transmembrane transport (GO:1902600) | 4.66617412 |
| 16 | ATP biosynthetic process (GO:0006754) | 4.43674174 |
| 17 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 4.35466936 |
| 18 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 4.28408634 |
| 19 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 4.22582574 |
| 20 | ATP hydrolysis coupled proton transport (GO:0015991) | 4.22582574 |
| 21 | proton transport (GO:0015992) | 4.15773765 |
| 22 | GTP biosynthetic process (GO:0006183) | 4.06741603 |
| 23 | hydrogen transport (GO:0006818) | 4.06564692 |
| 24 | oxidative phosphorylation (GO:0006119) | 4.02475626 |
| 25 | inner mitochondrial membrane organization (GO:0007007) | 3.89298271 |
| 26 | regulation of oxidative phosphorylation (GO:0002082) | 3.87835095 |
| 27 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 3.80705701 |
| 28 | cullin deneddylation (GO:0010388) | 3.73484745 |
| 29 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.73041909 |
| 30 | proteasome assembly (GO:0043248) | 3.70020669 |
| 31 | protein targeting to mitochondrion (GO:0006626) | 3.62409807 |
| 32 | establishment of protein localization to mitochondrion (GO:0072655) | 3.54637009 |
| 33 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.53261127 |
| 34 | dopamine transport (GO:0015872) | 3.48298749 |
| 35 | rRNA modification (GO:0000154) | 3.45688162 |
| 36 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.42727921 |
| 37 | protein deneddylation (GO:0000338) | 3.42009834 |
| 38 | transferrin transport (GO:0033572) | 3.36297342 |
| 39 | nucleoside triphosphate biosynthetic process (GO:0009142) | 3.36125120 |
| 40 | protein localization to mitochondrion (GO:0070585) | 3.32558324 |
| 41 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.29900927 |
| 42 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.29900927 |
| 43 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.29900927 |
| 44 | * cytochrome complex assembly (GO:0017004) | 3.27644024 |
| 45 | UTP biosynthetic process (GO:0006228) | 3.26306263 |
| 46 | protein-cofactor linkage (GO:0018065) | 3.25308067 |
| 47 | cotranslational protein targeting to membrane (GO:0006613) | 3.24731758 |
| 48 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.24519845 |
| 49 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.24519845 |
| 50 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.23961629 |
| 51 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.23685315 |
| 52 | signal peptide processing (GO:0006465) | 3.23242428 |
| 53 | * respiratory chain complex IV assembly (GO:0008535) | 3.22027705 |
| 54 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.21147101 |
| 55 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.15427693 |
| 56 | platelet dense granule organization (GO:0060155) | 3.15146926 |
| 57 | protein targeting to ER (GO:0045047) | 3.15098921 |
| 58 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.15026068 |
| 59 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.13568307 |
| 60 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.13568307 |
| 61 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.11338860 |
| 62 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.09561886 |
| 63 | aerobic respiration (GO:0009060) | 3.09372069 |
| 64 | protein localization to endoplasmic reticulum (GO:0070972) | 3.08396832 |
| 65 | trivalent inorganic cation transport (GO:0072512) | 3.08209234 |
| 66 | ferric iron transport (GO:0015682) | 3.08209234 |
| 67 | mitochondrial transport (GO:0006839) | 3.06835712 |
| 68 | DNA damage response, detection of DNA damage (GO:0042769) | 3.05776583 |
| 69 | sequestering of actin monomers (GO:0042989) | 3.04397158 |
| 70 | pseudouridine synthesis (GO:0001522) | 3.03770076 |
| 71 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.99875876 |
| 72 | protein maturation by protein folding (GO:0022417) | 2.96985395 |
| 73 | GDP-mannose metabolic process (GO:0019673) | 2.96789952 |
| 74 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.96430737 |
| 75 | * regulation of mitochondrial translation (GO:0070129) | 2.95487138 |
| 76 | presynaptic membrane assembly (GO:0097105) | 2.95261806 |
| 77 | positive regulation of ligase activity (GO:0051351) | 2.94073752 |
| 78 | aldehyde catabolic process (GO:0046185) | 2.93274749 |
| 79 | establishment of viral latency (GO:0019043) | 2.92416903 |
| 80 | establishment of integrated proviral latency (GO:0075713) | 2.89920019 |
| 81 | intracellular protein transmembrane import (GO:0044743) | 2.89122200 |
| 82 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.88714303 |
| 83 | termination of RNA polymerase III transcription (GO:0006386) | 2.88714303 |
| 84 | phagosome maturation (GO:0090382) | 2.88580495 |
| 85 | DNA deamination (GO:0045006) | 2.88424538 |
| 86 | regulation of cellular respiration (GO:0043457) | 2.86542832 |
| 87 | mannosylation (GO:0097502) | 2.85968952 |
| 88 | viral transcription (GO:0019083) | 2.85644586 |
| 89 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.84790462 |
| 90 | CTP metabolic process (GO:0046036) | 2.84624006 |
| 91 | CTP biosynthetic process (GO:0006241) | 2.84624006 |
| 92 | UTP metabolic process (GO:0046051) | 2.84621062 |
| 93 | nucleoside diphosphate phosphorylation (GO:0006165) | 2.84448575 |
| 94 | translation (GO:0006412) | 2.84232401 |
| 95 | ribosomal small subunit assembly (GO:0000028) | 2.84184378 |
| 96 | NADH metabolic process (GO:0006734) | 2.81191884 |
| 97 | peptidyl-histidine modification (GO:0018202) | 2.80586833 |
| 98 | ribosomal small subunit biogenesis (GO:0042274) | 2.79986501 |
| 99 | regulation of catecholamine metabolic process (GO:0042069) | 2.79561995 |
| 100 | regulation of dopamine metabolic process (GO:0042053) | 2.79561995 |
| 101 | positive regulation of mitochondrial fission (GO:0090141) | 2.77066810 |
| 102 | metallo-sulfur cluster assembly (GO:0031163) | 2.76650577 |
| 103 | iron-sulfur cluster assembly (GO:0016226) | 2.76650577 |
| 104 | translational termination (GO:0006415) | 2.75278483 |
| 105 | presynaptic membrane organization (GO:0097090) | 2.74957648 |
| 106 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.73847926 |
| 107 | protein localization to cilium (GO:0061512) | 2.73633546 |
| 108 | neuron cell-cell adhesion (GO:0007158) | 2.72571101 |
| 109 | negative regulation of ligase activity (GO:0051352) | 2.71252230 |
| 110 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.71252230 |
| 111 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.70336800 |
| 112 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.68761555 |
| 113 | substantia nigra development (GO:0021762) | 2.68689102 |
| 114 | 7-methylguanosine mRNA capping (GO:0006370) | 2.67370142 |
| 115 | regulation of cellular amine metabolic process (GO:0033238) | 2.67243055 |
| 116 | spliceosomal snRNP assembly (GO:0000387) | 2.65835935 |
| 117 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.64518853 |
| 118 | L-phenylalanine catabolic process (GO:0006559) | 2.64518853 |
| 119 | generation of precursor metabolites and energy (GO:0006091) | 2.63455317 |
| 120 | RNA capping (GO:0036260) | 2.62014292 |
| 121 | 7-methylguanosine RNA capping (GO:0009452) | 2.62014292 |
| 122 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.61735275 |
| 123 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.61735275 |
| 124 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.60789588 |
| 125 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.60344792 |
| 126 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.60188652 |
| 127 | regulation of hexokinase activity (GO:1903299) | 2.57848762 |
| 128 | regulation of glucokinase activity (GO:0033131) | 2.57848762 |
| 129 | regulation of ligase activity (GO:0051340) | 2.57495961 |
| 130 | chromatin remodeling at centromere (GO:0031055) | 2.56416691 |
| 131 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.54726777 |
| 132 | rRNA methylation (GO:0031167) | 2.53954100 |
| 133 | DNA double-strand break processing (GO:0000729) | 2.53775285 |
| 134 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 2.51805921 |
| 135 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 2.51805921 |
| 136 | C-terminal protein lipidation (GO:0006501) | 2.49697258 |
| 137 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.47567403 |
| 138 | positive regulation of cell cycle arrest (GO:0071158) | 2.46311064 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.37654317 |
| 2 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.79176501 |
| 3 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.61172159 |
| 4 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.55822582 |
| 5 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.42023577 |
| 6 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.41135901 |
| 7 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.33593606 |
| 8 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.02072722 |
| 9 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.97118575 |
| 10 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.94065050 |
| 11 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.93880764 |
| 12 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.88718205 |
| 13 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.76976555 |
| 14 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.48767136 |
| 15 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.48004041 |
| 16 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.46980885 |
| 17 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.35712039 |
| 18 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.25865570 |
| 19 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.18156701 |
| 20 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.16776586 |
| 21 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.13513648 |
| 22 | VDR_22108803_ChIP-Seq_LS180_Human | 1.97296046 |
| 23 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.92973341 |
| 24 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.84876609 |
| 25 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.80435149 |
| 26 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.70377100 |
| 27 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.69991475 |
| 28 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.65444297 |
| 29 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.59884390 |
| 30 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.59251672 |
| 31 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.58337427 |
| 32 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.58049948 |
| 33 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.48821001 |
| 34 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.48186770 |
| 35 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.47916924 |
| 36 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.47597731 |
| 37 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.47251270 |
| 38 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.46314303 |
| 39 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.46088293 |
| 40 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.45631465 |
| 41 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.45264478 |
| 42 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.45147611 |
| 43 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.44832994 |
| 44 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.42365852 |
| 45 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.41107927 |
| 46 | EWS_26573619_Chip-Seq_HEK293_Human | 1.40960949 |
| 47 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.40922102 |
| 48 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.39358598 |
| 49 | FUS_26573619_Chip-Seq_HEK293_Human | 1.38205149 |
| 50 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.37204104 |
| 51 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.35171569 |
| 52 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.34489535 |
| 53 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.32282701 |
| 54 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.30477836 |
| 55 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.29328626 |
| 56 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.29155371 |
| 57 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.28659055 |
| 58 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.27966244 |
| 59 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.27372892 |
| 60 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.26513841 |
| 61 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.25097331 |
| 62 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.23874411 |
| 63 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.23187782 |
| 64 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.22901887 |
| 65 | P300_19829295_ChIP-Seq_ESCs_Human | 1.22833605 |
| 66 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.19215745 |
| 67 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.19109740 |
| 68 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.17965355 |
| 69 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.14765816 |
| 70 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.13995628 |
| 71 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.11432093 |
| 72 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.10748641 |
| 73 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.10216382 |
| 74 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.09942792 |
| 75 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.09264233 |
| 76 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.08764216 |
| 77 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.07900816 |
| 78 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.06814527 |
| 79 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.06640293 |
| 80 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.05370586 |
| 81 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.05238206 |
| 82 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.05208576 |
| 83 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.05056798 |
| 84 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.05004291 |
| 85 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.05004291 |
| 86 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.04328451 |
| 87 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.04133038 |
| 88 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.03611414 |
| 89 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.03298041 |
| 90 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.00805981 |
| 91 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.00805981 |
| 92 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.99377811 |
| 93 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.97766101 |
| 94 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.95758058 |
| 95 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.95577543 |
| 96 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.95219206 |
| 97 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.95173969 |
| 98 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.95049671 |
| 99 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.94669748 |
| 100 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.94114432 |
| 101 | AR_20517297_ChIP-Seq_VCAP_Human | 0.93982880 |
| 102 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.93574093 |
| 103 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.93301971 |
| 104 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.93300563 |
| 105 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.92738261 |
| 106 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.92073437 |
| 107 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.90225897 |
| 108 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.89306640 |
| 109 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.89081294 |
| 110 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.87309960 |
| 111 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.85901336 |
| 112 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.85679332 |
| 113 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.85605935 |
| 114 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.85562069 |
| 115 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.85428864 |
| 116 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.85231243 |
| 117 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.85230446 |
| 118 | JUN_21703547_ChIP-Seq_K562_Human | 0.85191041 |
| 119 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.85171854 |
| 120 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.85034767 |
| 121 | NCOR_22424771_ChIP-Seq_293T_Human | 0.84700706 |
| 122 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.84553852 |
| 123 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.84519811 |
| 124 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.83788570 |
| 125 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.82906301 |
| 126 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.82406627 |
| 127 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.82082092 |
| 128 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.81437897 |
| 129 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.81187885 |
| 130 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.77520875 |
| 131 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.71868260 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.32854912 |
| 2 | MP0001529_abnormal_vocalization | 3.83475751 |
| 3 | MP0009379_abnormal_foot_pigmentation | 3.06707549 |
| 4 | MP0006276_abnormal_autonomic_nervous | 2.94517041 |
| 5 | MP0002837_dystrophic_cardiac_calcinosis | 2.79687577 |
| 6 | MP0001905_abnormal_dopamine_level | 2.74811239 |
| 7 | MP0002736_abnormal_nociception_after | 2.57626489 |
| 8 | MP0001968_abnormal_touch/_nociception | 2.55206434 |
| 9 | MP0002876_abnormal_thyroid_physiology | 2.51319829 |
| 10 | MP0010386_abnormal_urinary_bladder | 2.43239645 |
| 11 | MP0001986_abnormal_taste_sensitivity | 2.25633808 |
| 12 | MP0003011_delayed_dark_adaptation | 2.21616764 |
| 13 | MP0008877_abnormal_DNA_methylation | 2.21259016 |
| 14 | MP0002064_seizures | 2.19967689 |
| 15 | MP0002822_catalepsy | 2.19538026 |
| 16 | MP0002272_abnormal_nervous_system | 2.15033160 |
| 17 | MP0009745_abnormal_behavioral_response | 2.14592771 |
| 18 | MP0002735_abnormal_chemical_nociception | 2.14313163 |
| 19 | MP0006036_abnormal_mitochondrial_physio | 2.14205912 |
| 20 | MP0002938_white_spotting | 2.13947399 |
| 21 | MP0008058_abnormal_DNA_repair | 2.13368674 |
| 22 | MP0009046_muscle_twitch | 2.07022881 |
| 23 | MP0003635_abnormal_synaptic_transmissio | 2.05777835 |
| 24 | MP0006292_abnormal_olfactory_placode | 2.05259511 |
| 25 | MP0002734_abnormal_mechanical_nocicepti | 2.00452692 |
| 26 | MP0004270_analgesia | 2.00225664 |
| 27 | MP0004142_abnormal_muscle_tone | 1.98958976 |
| 28 | MP0002102_abnormal_ear_morphology | 1.96287829 |
| 29 | MP0001188_hyperpigmentation | 1.92593254 |
| 30 | MP0002163_abnormal_gland_morphology | 1.91771154 |
| 31 | MP0003122_maternal_imprinting | 1.88813756 |
| 32 | MP0005379_endocrine/exocrine_gland_phen | 1.87572465 |
| 33 | MP0005645_abnormal_hypothalamus_physiol | 1.85426383 |
| 34 | MP0002572_abnormal_emotion/affect_behav | 1.84268752 |
| 35 | MP0008875_abnormal_xenobiotic_pharmacok | 1.83539002 |
| 36 | MP0004043_abnormal_pH_regulation | 1.82776413 |
| 37 | MP0003718_maternal_effect | 1.76306096 |
| 38 | MP0000013_abnormal_adipose_tissue | 1.75203991 |
| 39 | MP0005646_abnormal_pituitary_gland | 1.74478953 |
| 40 | MP0002638_abnormal_pupillary_reflex | 1.72710097 |
| 41 | MP0001984_abnormal_olfaction | 1.71703999 |
| 42 | MP0001970_abnormal_pain_threshold | 1.71175470 |
| 43 | MP0006035_abnormal_mitochondrial_morpho | 1.69822821 |
| 44 | MP0002067_abnormal_sensory_capabilities | 1.67845884 |
| 45 | MP0001440_abnormal_grooming_behavior | 1.67151244 |
| 46 | MP0002733_abnormal_thermal_nociception | 1.64687569 |
| 47 | MP0005423_abnormal_somatic_nervous | 1.64007526 |
| 48 | MP0002063_abnormal_learning/memory/cond | 1.62611913 |
| 49 | MP0003786_premature_aging | 1.60642497 |
| 50 | MP0004859_abnormal_synaptic_plasticity | 1.54316121 |
| 51 | MP0001501_abnormal_sleep_pattern | 1.53770867 |
| 52 | MP0005386_behavior/neurological_phenoty | 1.51230712 |
| 53 | MP0004924_abnormal_behavior | 1.51230712 |
| 54 | MP0003121_genomic_imprinting | 1.48513898 |
| 55 | MP0002139_abnormal_hepatobiliary_system | 1.46999813 |
| 56 | MP0005171_absent_coat_pigmentation | 1.46704703 |
| 57 | MP0003195_calcinosis | 1.44420647 |
| 58 | MP0005332_abnormal_amino_acid | 1.42541047 |
| 59 | MP0001664_abnormal_digestion | 1.40799811 |
| 60 | MP0001486_abnormal_startle_reflex | 1.36520802 |
| 61 | MP0006072_abnormal_retinal_apoptosis | 1.36152461 |
| 62 | MP0004133_heterotaxia | 1.35423294 |
| 63 | MP0004147_increased_porphyrin_level | 1.31638478 |
| 64 | MP0002184_abnormal_innervation | 1.19853628 |
| 65 | MP0005084_abnormal_gallbladder_morpholo | 1.16556104 |
| 66 | MP0009697_abnormal_copulation | 1.16344501 |
| 67 | MP0000372_irregular_coat_pigmentation | 1.15342724 |
| 68 | MP0002557_abnormal_social/conspecific_i | 1.13702882 |
| 69 | MP0003693_abnormal_embryo_hatching | 1.13058797 |
| 70 | MP0002090_abnormal_vision | 1.11837753 |
| 71 | MP0001485_abnormal_pinna_reflex | 1.10455621 |
| 72 | MP0004019_abnormal_vitamin_homeostasis | 1.10389294 |
| 73 | MP0008872_abnormal_physiological_respon | 1.09986202 |
| 74 | MP0003136_yellow_coat_color | 1.08869914 |
| 75 | MP0005551_abnormal_eye_electrophysiolog | 1.08772391 |
| 76 | MP0008995_early_reproductive_senescence | 1.07287942 |
| 77 | MP0002653_abnormal_ependyma_morphology | 1.07233551 |
| 78 | MP0001756_abnormal_urination | 1.06591641 |
| 79 | MP0005075_abnormal_melanosome_morpholog | 1.05215636 |
| 80 | MP0003787_abnormal_imprinting | 1.05186234 |
| 81 | MP0000516_abnormal_urinary_system | 1.04630117 |
| 82 | MP0005367_renal/urinary_system_phenotyp | 1.04630117 |
| 83 | MP0002751_abnormal_autonomic_nervous | 1.04402200 |
| 84 | MP0005636_abnormal_mineral_homeostasis | 1.02276663 |
| 85 | MP0005535_abnormal_body_temperature | 1.01548996 |
| 86 | MP0005085_abnormal_gallbladder_physiolo | 1.01310473 |
| 87 | MP0002229_neurodegeneration | 1.00096698 |
| 88 | MP0002277_abnormal_respiratory_mucosa | 0.99536773 |
| 89 | MP0002066_abnormal_motor_capabilities/c | 0.99268381 |
| 90 | MP0000778_abnormal_nervous_system | 0.97963371 |
| 91 | MP0003186_abnormal_redox_activity | 0.94619404 |
| 92 | MP0004215_abnormal_myocardial_fiber | 0.93685976 |
| 93 | MP0005409_darkened_coat_color | 0.93547272 |
| 94 | MP0001963_abnormal_hearing_physiology | 0.93380908 |
| 95 | MP0009780_abnormal_chondrocyte_physiolo | 0.93012697 |
| 96 | MP0002693_abnormal_pancreas_physiology | 0.92767249 |
| 97 | MP0001764_abnormal_homeostasis | 0.92490358 |
| 98 | MP0005253_abnormal_eye_physiology | 0.92450778 |
| 99 | MP0005365_abnormal_bile_salt | 0.91970161 |
| 100 | MP0003879_abnormal_hair_cell | 0.89578213 |
| 101 | MP0010094_abnormal_chromosome_stability | 0.89357778 |
| 102 | MP0001502_abnormal_circadian_rhythm | 0.88959620 |
| 103 | MP0003806_abnormal_nucleotide_metabolis | 0.88426413 |
| 104 | MP0000538_abnormal_urinary_bladder | 0.88176676 |
| 105 | MP0005408_hypopigmentation | 0.88000663 |
| 106 | MP0004742_abnormal_vestibular_system | 0.86770224 |
| 107 | MP0004145_abnormal_muscle_electrophysio | 0.86714860 |
| 108 | MP0001293_anophthalmia | 0.86365840 |
| 109 | MP0001944_abnormal_pancreas_morphology | 0.85897295 |
| 110 | MP0008004_abnormal_stomach_pH | 0.85736571 |
| 111 | MP0003283_abnormal_digestive_organ | 0.85086886 |
| 112 | MP0003938_abnormal_ear_development | 0.84801768 |
| 113 | MP0008789_abnormal_olfactory_epithelium | 0.82327371 |
| 114 | MP0002095_abnormal_skin_pigmentation | 0.82258829 |
| 115 | MP0002882_abnormal_neuron_morphology | 0.82191971 |
| 116 | MP0004957_abnormal_blastocyst_morpholog | 0.81744721 |
| 117 | MP0005499_abnormal_olfactory_system | 0.81023655 |
| 118 | MP0005394_taste/olfaction_phenotype | 0.81023655 |
| 119 | MP0010329_abnormal_lipoprotein_level | 0.80453650 |
| 120 | MP0004036_abnormal_muscle_relaxation | 0.79399046 |
| 121 | MP0003329_amyloid_beta_deposits | 0.78476046 |
| 122 | MP0000026_abnormal_inner_ear | 0.78182652 |
| 123 | MP0000749_muscle_degeneration | 0.76904252 |
| 124 | MP0000631_abnormal_neuroendocrine_gland | 0.76664188 |
| 125 | MP0005389_reproductive_system_phenotype | 0.76469859 |
| 126 | MP0003137_abnormal_impulse_conducting | 0.75739811 |
| 127 | MP0002160_abnormal_reproductive_system | 0.75697767 |
| 128 | MP0000230_abnormal_systemic_arterial | 0.74103437 |
| 129 | MP0002909_abnormal_adrenal_gland | 0.74094340 |
| 130 | MP0001727_abnormal_embryo_implantation | 0.74034354 |
| 131 | MP0002234_abnormal_pharynx_morphology | 0.72592027 |
| 132 | MP0008569_lethality_at_weaning | 0.72350034 |
| 133 | MP0002069_abnormal_eating/drinking_beha | 0.71846250 |
| 134 | MP0000955_abnormal_spinal_cord | 0.71150710 |
| 135 | MP0000751_myopathy | 0.71134701 |
| 136 | MP0003123_paternal_imprinting | 0.68717894 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 7.46243125 |
| 2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 6.94881808 |
| 3 | Mitochondrial inheritance (HP:0001427) | 6.74510688 |
| 4 | Progressive macrocephaly (HP:0004481) | 6.29576652 |
| 5 | Acute encephalopathy (HP:0006846) | 6.21995838 |
| 6 | Hepatocellular necrosis (HP:0001404) | 5.84806927 |
| 7 | Increased CSF lactate (HP:0002490) | 5.71553017 |
| 8 | Hepatic necrosis (HP:0002605) | 5.12058789 |
| 9 | Increased hepatocellular lipid droplets (HP:0006565) | 5.05721970 |
| 10 | Lipid accumulation in hepatocytes (HP:0006561) | 4.53967514 |
| 11 | Renal Fanconi syndrome (HP:0001994) | 4.41947522 |
| 12 | Cerebral edema (HP:0002181) | 4.14799383 |
| 13 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 4.04281499 |
| 14 | Increased intramyocellular lipid droplets (HP:0012240) | 3.95621479 |
| 15 | Respiratory failure (HP:0002878) | 3.92259486 |
| 16 | Lactic acidosis (HP:0003128) | 3.78710962 |
| 17 | Exercise intolerance (HP:0003546) | 3.78075990 |
| 18 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.75147400 |
| 19 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.75147400 |
| 20 | Optic disc pallor (HP:0000543) | 3.74221813 |
| 21 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.63066569 |
| 22 | Increased serum lactate (HP:0002151) | 3.57206970 |
| 23 | Leukodystrophy (HP:0002415) | 3.56762619 |
| 24 | Increased serum pyruvate (HP:0003542) | 3.53477412 |
| 25 | Abnormality of glycolysis (HP:0004366) | 3.53477412 |
| 26 | 3-Methylglutaconic aciduria (HP:0003535) | 3.49848026 |
| 27 | Increased muscle lipid content (HP:0009058) | 3.33979251 |
| 28 | Exertional dyspnea (HP:0002875) | 3.25152067 |
| 29 | Neuroendocrine neoplasm (HP:0100634) | 3.23362178 |
| 30 | Pheochromocytoma (HP:0002666) | 3.20961417 |
| 31 | Abnormality of renal resorption (HP:0011038) | 3.10330024 |
| 32 | Hypothermia (HP:0002045) | 2.87751487 |
| 33 | Focal motor seizures (HP:0011153) | 2.80076047 |
| 34 | Respiratory difficulties (HP:0002880) | 2.78322646 |
| 35 | Emotional lability (HP:0000712) | 2.70693367 |
| 36 | CNS demyelination (HP:0007305) | 2.69965638 |
| 37 | Pancreatic cysts (HP:0001737) | 2.63675970 |
| 38 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.61766809 |
| 39 | Glycosuria (HP:0003076) | 2.59759614 |
| 40 | Abnormality of urine glucose concentration (HP:0011016) | 2.59759614 |
| 41 | Abnormality of the labia minora (HP:0012880) | 2.58980614 |
| 42 | Hyperphosphaturia (HP:0003109) | 2.58061798 |
| 43 | Pancreatic fibrosis (HP:0100732) | 2.56826929 |
| 44 | Medial flaring of the eyebrow (HP:0010747) | 2.55963823 |
| 45 | Hyperglycinemia (HP:0002154) | 2.54203290 |
| 46 | True hermaphroditism (HP:0010459) | 2.48801152 |
| 47 | X-linked dominant inheritance (HP:0001423) | 2.48520942 |
| 48 | Myokymia (HP:0002411) | 2.45343766 |
| 49 | Abnormality of midbrain morphology (HP:0002418) | 2.41986757 |
| 50 | Molar tooth sign on MRI (HP:0002419) | 2.41986757 |
| 51 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.38216452 |
| 52 | Atonic seizures (HP:0010819) | 2.36725686 |
| 53 | Gait imbalance (HP:0002141) | 2.34980487 |
| 54 | Abnormal pupillary function (HP:0007686) | 2.32450241 |
| 55 | Congenital, generalized hypertrichosis (HP:0004540) | 2.29540097 |
| 56 | Congenital primary aphakia (HP:0007707) | 2.29151929 |
| 57 | Poor suck (HP:0002033) | 2.28680088 |
| 58 | Generalized aminoaciduria (HP:0002909) | 2.25604718 |
| 59 | Limb dystonia (HP:0002451) | 2.25031813 |
| 60 | Lethargy (HP:0001254) | 2.24931592 |
| 61 | Nephrogenic diabetes insipidus (HP:0009806) | 2.23653669 |
| 62 | Nephronophthisis (HP:0000090) | 2.20730518 |
| 63 | Hypoglycemic coma (HP:0001325) | 2.19826277 |
| 64 | Microvesicular hepatic steatosis (HP:0001414) | 2.17262802 |
| 65 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.14174984 |
| 66 | Abnormal hair whorl (HP:0010721) | 2.06909249 |
| 67 | Degeneration of anterior horn cells (HP:0002398) | 2.06125661 |
| 68 | Abnormality of the anterior horn cell (HP:0006802) | 2.06125661 |
| 69 | Abnormal urine phosphate concentration (HP:0012599) | 2.05255819 |
| 70 | Renal tubular dysfunction (HP:0000124) | 2.03195090 |
| 71 | Colon cancer (HP:0003003) | 2.01935882 |
| 72 | Ketoacidosis (HP:0001993) | 2.00080034 |
| 73 | Abnormal number of erythroid precursors (HP:0012131) | 1.96826767 |
| 74 | Hyperventilation (HP:0002883) | 1.96271545 |
| 75 | Reticulocytopenia (HP:0001896) | 1.95952594 |
| 76 | Type I transferrin isoform profile (HP:0003642) | 1.94337773 |
| 77 | Epileptic encephalopathy (HP:0200134) | 1.92560643 |
| 78 | Abnormality of vitamin B metabolism (HP:0004340) | 1.91788241 |
| 79 | Gliosis (HP:0002171) | 1.88189621 |
| 80 | Vaginal atresia (HP:0000148) | 1.88056081 |
| 81 | Sclerocornea (HP:0000647) | 1.88013651 |
| 82 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.86360176 |
| 83 | Dicarboxylic aciduria (HP:0003215) | 1.86360176 |
| 84 | Delusions (HP:0000746) | 1.83870600 |
| 85 | Genital tract atresia (HP:0001827) | 1.83858912 |
| 86 | Large for gestational age (HP:0001520) | 1.82754113 |
| 87 | Absence seizures (HP:0002121) | 1.82618003 |
| 88 | Methylmalonic aciduria (HP:0012120) | 1.82563849 |
| 89 | Anxiety (HP:0000739) | 1.79388089 |
| 90 | Visual hallucinations (HP:0002367) | 1.78060050 |
| 91 | Methylmalonic acidemia (HP:0002912) | 1.77589921 |
| 92 | Abnormality of glycine metabolism (HP:0010895) | 1.77091933 |
| 93 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.77091933 |
| 94 | Oral leukoplakia (HP:0002745) | 1.76836786 |
| 95 | Abnormality of serum amino acid levels (HP:0003112) | 1.76193347 |
| 96 | Dialeptic seizures (HP:0011146) | 1.75741768 |
| 97 | Hyperglycinuria (HP:0003108) | 1.75399761 |
| 98 | Hypomagnesemia (HP:0002917) | 1.74537766 |
| 99 | Intestinal atresia (HP:0011100) | 1.73251264 |
| 100 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.72955901 |
| 101 | Macrocytic anemia (HP:0001972) | 1.71764978 |
| 102 | Congenital stationary night blindness (HP:0007642) | 1.71755652 |
| 103 | Delayed CNS myelination (HP:0002188) | 1.71493309 |
| 104 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.71293003 |
| 105 | Ketosis (HP:0001946) | 1.71069304 |
| 106 | Abnormality of methionine metabolism (HP:0010901) | 1.70802991 |
| 107 | Abnormality of the renal medulla (HP:0100957) | 1.70545230 |
| 108 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.70503425 |
| 109 | Male pseudohermaphroditism (HP:0000037) | 1.68683891 |
| 110 | Septo-optic dysplasia (HP:0100842) | 1.68590905 |
| 111 | Parakeratosis (HP:0001036) | 1.66782470 |
| 112 | Pendular nystagmus (HP:0012043) | 1.66369368 |
| 113 | Abnormality of placental membranes (HP:0011409) | 1.65833856 |
| 114 | Amniotic constriction ring (HP:0009775) | 1.65833856 |
| 115 | Hypoglycemic seizures (HP:0002173) | 1.65111571 |
| 116 | Retinal dysplasia (HP:0007973) | 1.64341299 |
| 117 | Blindness (HP:0000618) | 1.64033641 |
| 118 | Congenital sensorineural hearing impairment (HP:0008527) | 1.63071605 |
| 119 | Oligomenorrhea (HP:0000876) | 1.60400438 |
| 120 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.59405560 |
| 121 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.59405560 |
| 122 | Abnormal protein glycosylation (HP:0012346) | 1.59405560 |
| 123 | Abnormal glycosylation (HP:0012345) | 1.59405560 |
| 124 | Cerebral hypomyelination (HP:0006808) | 1.59072378 |
| 125 | Palpitations (HP:0001962) | 1.58294165 |
| 126 | Vomiting (HP:0002013) | 1.57670077 |
| 127 | Aplastic anemia (HP:0001915) | 1.57420143 |
| 128 | Septate vagina (HP:0001153) | 1.55266833 |
| 129 | Polyphagia (HP:0002591) | 1.54930527 |
| 130 | Cerebral hemorrhage (HP:0001342) | 1.54099604 |
| 131 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.53519711 |
| 132 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.53229989 |
| 133 | Vacuolated lymphocytes (HP:0001922) | 1.52278789 |
| 134 | Conjunctival hamartoma (HP:0100780) | 1.51788672 |
| 135 | Hypoplasia of the uterus (HP:0000013) | 1.50576969 |
| 136 | Abnormality of alanine metabolism (HP:0010916) | 1.48869773 |
| 137 | Hyperalaninemia (HP:0003348) | 1.48869773 |
| 138 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.48869773 |
| 139 | Hypokinesia (HP:0002375) | 1.46441753 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K12 | 4.35145615 |
| 2 | VRK2 | 4.06655196 |
| 3 | NME1 | 3.72537958 |
| 4 | CASK | 3.63607926 |
| 5 | STK16 | 3.22532918 |
| 6 | MAP4K2 | 3.10338648 |
| 7 | ZAK | 2.53369024 |
| 8 | MAP2K7 | 2.42832000 |
| 9 | ARAF | 2.37847568 |
| 10 | MYLK | 2.25825351 |
| 11 | FRK | 2.18319277 |
| 12 | NUAK1 | 2.17936880 |
| 13 | NME2 | 2.15499824 |
| 14 | BUB1 | 2.05199999 |
| 15 | BRAF | 2.00867527 |
| 16 | GRK5 | 1.85778394 |
| 17 | OXSR1 | 1.81489779 |
| 18 | CDK19 | 1.73132747 |
| 19 | NTRK3 | 1.72443497 |
| 20 | GRK7 | 1.68410314 |
| 21 | STK39 | 1.67492989 |
| 22 | NEK1 | 1.66745346 |
| 23 | MST4 | 1.63023923 |
| 24 | WNK4 | 1.61499353 |
| 25 | MAP3K4 | 1.60574280 |
| 26 | TRIM28 | 1.58334443 |
| 27 | PLK3 | 1.55135112 |
| 28 | VRK1 | 1.55013529 |
| 29 | BMPR1B | 1.52459745 |
| 30 | BMPR2 | 1.49103170 |
| 31 | GRK1 | 1.48505817 |
| 32 | BCR | 1.48468044 |
| 33 | PBK | 1.46537753 |
| 34 | EIF2AK3 | 1.41747845 |
| 35 | ADRBK2 | 1.39446760 |
| 36 | TNIK | 1.33944029 |
| 37 | PNCK | 1.27925045 |
| 38 | MUSK | 1.27182631 |
| 39 | PLK2 | 1.22968265 |
| 40 | EIF2AK1 | 1.20247907 |
| 41 | CDC7 | 1.19997062 |
| 42 | CAMK2B | 1.16350004 |
| 43 | WNK3 | 1.15521888 |
| 44 | MAPK13 | 1.14548198 |
| 45 | CDK8 | 1.10890434 |
| 46 | BCKDK | 1.10843323 |
| 47 | EPHA4 | 1.10557506 |
| 48 | TESK1 | 1.07140737 |
| 49 | DAPK1 | 1.06719882 |
| 50 | PLK4 | 1.06502618 |
| 51 | MAPKAPK5 | 1.05940730 |
| 52 | TSSK6 | 1.05831710 |
| 53 | AKT3 | 1.05136764 |
| 54 | TLK1 | 1.03890999 |
| 55 | LIMK1 | 1.02916745 |
| 56 | PDK2 | 1.01772591 |
| 57 | MARK1 | 1.01390315 |
| 58 | MINK1 | 1.00851066 |
| 59 | CSNK1A1L | 0.99434514 |
| 60 | RIPK4 | 0.97626758 |
| 61 | UHMK1 | 0.96498730 |
| 62 | CAMK2A | 0.96108375 |
| 63 | WEE1 | 0.95218594 |
| 64 | CAMK2D | 0.94027878 |
| 65 | ADRBK1 | 0.92978571 |
| 66 | PLK1 | 0.92882033 |
| 67 | TAF1 | 0.89422064 |
| 68 | CCNB1 | 0.89340391 |
| 69 | BRSK2 | 0.88694194 |
| 70 | CSNK1G3 | 0.86873232 |
| 71 | PAK3 | 0.86031665 |
| 72 | MAP2K4 | 0.85292817 |
| 73 | CAMK2G | 0.84796210 |
| 74 | DYRK2 | 0.84463170 |
| 75 | OBSCN | 0.82685706 |
| 76 | PRKCE | 0.81854918 |
| 77 | SRPK1 | 0.80444352 |
| 78 | MKNK2 | 0.78307535 |
| 79 | TTK | 0.77982220 |
| 80 | ACVR1B | 0.75171139 |
| 81 | BRSK1 | 0.74807337 |
| 82 | ERBB3 | 0.73384354 |
| 83 | PRKCG | 0.71875043 |
| 84 | RPS6KA5 | 0.69980843 |
| 85 | ABL2 | 0.69920998 |
| 86 | PIM2 | 0.68875512 |
| 87 | MAPKAPK3 | 0.68727432 |
| 88 | FGFR2 | 0.67524529 |
| 89 | DAPK2 | 0.64251804 |
| 90 | KDR | 0.63121975 |
| 91 | CDK5 | 0.60551241 |
| 92 | PRKCI | 0.59297588 |
| 93 | CDK14 | 0.58290693 |
| 94 | PRKACA | 0.58280830 |
| 95 | INSRR | 0.57864141 |
| 96 | MAP2K2 | 0.57372388 |
| 97 | SIK3 | 0.56533908 |
| 98 | LMTK2 | 0.55182564 |
| 99 | MAPK15 | 0.54046965 |
| 100 | MKNK1 | 0.53891977 |
| 101 | AURKB | 0.53418857 |
| 102 | DAPK3 | 0.52087285 |
| 103 | AURKA | 0.51786715 |
| 104 | CSNK1A1 | 0.49703835 |
| 105 | CDK18 | 0.49565968 |
| 106 | NTRK1 | 0.48399705 |
| 107 | STK38L | 0.47727983 |
| 108 | TIE1 | 0.46633681 |
| 109 | CSNK1G2 | 0.45917552 |
| 110 | SGK223 | 0.44502932 |
| 111 | SGK494 | 0.44502932 |
| 112 | PTK2B | 0.43387125 |
| 113 | CAMKK2 | 0.43249240 |
| 114 | CDK15 | 0.42478977 |
| 115 | CSNK1G1 | 0.41821741 |
| 116 | STK4 | 0.41739876 |
| 117 | CSNK2A1 | 0.40717056 |
| 118 | CSNK1E | 0.40367509 |
| 119 | CDK11A | 0.39692121 |
| 120 | NEK6 | 0.39640592 |
| 121 | PDK3 | 0.39309533 |
| 122 | PDK4 | 0.39309533 |
| 123 | PASK | 0.39207274 |
| 124 | PKN1 | 0.39132126 |
| 125 | FGR | 0.38493213 |
| 126 | ILK | 0.38040232 |
| 127 | MST1R | 0.37705431 |
| 128 | DYRK1A | 0.37369767 |
| 129 | TESK2 | 0.37304857 |
| 130 | CSNK2A2 | 0.37207155 |
| 131 | PIK3CG | 0.37100426 |
| 132 | YES1 | 0.37025222 |
| 133 | MAP3K9 | 0.36788107 |
| 134 | MAP3K11 | 0.35785762 |
| 135 | PINK1 | 0.34823035 |
| 136 | PHKG2 | 0.34493790 |
| 137 | PHKG1 | 0.34493790 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 6.33435771 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 5.24924056 |
| 3 | Alzheimers disease_Homo sapiens_hsa05010 | 4.04676703 |
| 4 | Huntingtons disease_Homo sapiens_hsa05016 | 3.67518262 |
| 5 | Protein export_Homo sapiens_hsa03060 | 3.44208914 |
| 6 | Proteasome_Homo sapiens_hsa03050 | 3.37570597 |
| 7 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 3.18491818 |
| 8 | Ribosome_Homo sapiens_hsa03010 | 3.16516389 |
| 9 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.98983317 |
| 10 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.31312729 |
| 11 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.21505954 |
| 12 | RNA polymerase_Homo sapiens_hsa03020 | 1.96836211 |
| 13 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.92793980 |
| 14 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.81908511 |
| 15 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.74075602 |
| 16 | Nicotine addiction_Homo sapiens_hsa05033 | 1.61372905 |
| 17 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.53164886 |
| 18 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.51140030 |
| 19 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.44732432 |
| 20 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.42728152 |
| 21 | DNA replication_Homo sapiens_hsa03030 | 1.38100434 |
| 22 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.35747372 |
| 23 | Base excision repair_Homo sapiens_hsa03410 | 1.16310551 |
| 24 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.12505577 |
| 25 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.11103526 |
| 26 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.11036073 |
| 27 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.10796011 |
| 28 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.07900508 |
| 29 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.05949088 |
| 30 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.04020819 |
| 31 | Sulfur relay system_Homo sapiens_hsa04122 | 1.03710475 |
| 32 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.02640163 |
| 33 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.02446968 |
| 34 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.02143363 |
| 35 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.00904308 |
| 36 | Taste transduction_Homo sapiens_hsa04742 | 1.00871360 |
| 37 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.00012375 |
| 38 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.98125877 |
| 39 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.97605922 |
| 40 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.97312826 |
| 41 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.97278330 |
| 42 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.96960304 |
| 43 | GABAergic synapse_Homo sapiens_hsa04727 | 0.96659676 |
| 44 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.95401601 |
| 45 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.95047092 |
| 46 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.90779377 |
| 47 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.89311190 |
| 48 | Metabolic pathways_Homo sapiens_hsa01100 | 0.86062999 |
| 49 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.84633296 |
| 50 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.82198157 |
| 51 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.80510309 |
| 52 | Morphine addiction_Homo sapiens_hsa05032 | 0.79734924 |
| 53 | Retinol metabolism_Homo sapiens_hsa00830 | 0.79509400 |
| 54 | Purine metabolism_Homo sapiens_hsa00230 | 0.77431466 |
| 55 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.76385899 |
| 56 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.74999613 |
| 57 | Phototransduction_Homo sapiens_hsa04744 | 0.74509122 |
| 58 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.74209300 |
| 59 | Insulin secretion_Homo sapiens_hsa04911 | 0.72501538 |
| 60 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.70191680 |
| 61 | RNA transport_Homo sapiens_hsa03013 | 0.69741896 |
| 62 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.69434530 |
| 63 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.67239371 |
| 64 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.65819951 |
| 65 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.65817049 |
| 66 | Phagosome_Homo sapiens_hsa04145 | 0.65337343 |
| 67 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.64575178 |
| 68 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.63843575 |
| 69 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.63203764 |
| 70 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.61733598 |
| 71 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.60535045 |
| 72 | Circadian entrainment_Homo sapiens_hsa04713 | 0.60418381 |
| 73 | Cocaine addiction_Homo sapiens_hsa05030 | 0.57811764 |
| 74 | Mineral absorption_Homo sapiens_hsa04978 | 0.57523237 |
| 75 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.56637627 |
| 76 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.56283562 |
| 77 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.55715116 |
| 78 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.53799256 |
| 79 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.53209829 |
| 80 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.52761091 |
| 81 | Other glycan degradation_Homo sapiens_hsa00511 | 0.52266917 |
| 82 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.52016187 |
| 83 | Olfactory transduction_Homo sapiens_hsa04740 | 0.51218514 |
| 84 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.50717242 |
| 85 | Histidine metabolism_Homo sapiens_hsa00340 | 0.50404970 |
| 86 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.50325432 |
| 87 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.49356252 |
| 88 | Long-term potentiation_Homo sapiens_hsa04720 | 0.49038830 |
| 89 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.48275509 |
| 90 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.46882018 |
| 91 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.45852563 |
| 92 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.44631894 |
| 93 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.44387014 |
| 94 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.43470847 |
| 95 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.43071499 |
| 96 | Basal transcription factors_Homo sapiens_hsa03022 | 0.41701511 |
| 97 | Long-term depression_Homo sapiens_hsa04730 | 0.40438010 |
| 98 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.39606873 |
| 99 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.39257301 |
| 100 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.38980972 |
| 101 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.38934302 |
| 102 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.37608943 |
| 103 | Carbon metabolism_Homo sapiens_hsa01200 | 0.36912398 |
| 104 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.36904201 |
| 105 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.36250241 |
| 106 | Peroxisome_Homo sapiens_hsa04146 | 0.36164711 |
| 107 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.35687811 |
| 108 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.34412250 |
| 109 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.34117371 |
| 110 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.33678315 |
| 111 | Spliceosome_Homo sapiens_hsa03040 | 0.32478868 |
| 112 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.32317867 |
| 113 | RNA degradation_Homo sapiens_hsa03018 | 0.30961180 |
| 114 | Renin secretion_Homo sapiens_hsa04924 | 0.30933479 |
| 115 | Homologous recombination_Homo sapiens_hsa03440 | 0.30617482 |
| 116 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.29917576 |
| 117 | Salivary secretion_Homo sapiens_hsa04970 | 0.27926782 |
| 118 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.27271022 |
| 119 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.24692125 |
| 120 | Alcoholism_Homo sapiens_hsa05034 | 0.24231054 |
| 121 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.22676926 |
| 122 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.22592988 |
| 123 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.21990783 |
| 124 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.20944424 |
| 125 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.20602111 |
| 126 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.20090211 |
| 127 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.19734509 |
| 128 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.19120582 |
| 129 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.18576851 |
| 130 | Mismatch repair_Homo sapiens_hsa03430 | 0.16549061 |
| 131 | Galactose metabolism_Homo sapiens_hsa00052 | 0.16322052 |
| 132 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.15351532 |
| 133 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.14535934 |

